The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
Dr. Jitendra Singh inaugurates 300 LPM capacity Oxygen Plant, Day Care Chemotherapy Unit affiliated to Tata Memorial Hospital & Maternal ICU at GMC Kathua
The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Clindamycin Phosphate Gel is used to treat acne
InvaGen has received 5 inspectional observations in Form 483
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
Subscribe To Our Newsletter & Stay Updated
